These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 196190)
1. [Guidelines to the therapie of the most important rheumatic diseases (author's transl)]. Heimstädt P MMW Munch Med Wochenschr; 1977 Jun; 119(22):773-82. PubMed ID: 196190 [TBL] [Abstract][Full Text] [Related]
2. [Problems of rheumatic therapy in pregnancy (author's transl)]. Bischof P MMW Munch Med Wochenschr; 1976 Oct; 118(41):1323-6. PubMed ID: 825725 [TBL] [Abstract][Full Text] [Related]
3. [Problems of basic therapy of rheumatic diseases with chloroquine, gold and D-penicillamine]. Meyer W; Weyerbrock W Internist (Berl); 1979 Sep; 20(9):426-32. PubMed ID: 115810 [No Abstract] [Full Text] [Related]
4. [Anti-inflammatory or antirheumatic agents? Pharmacological activity and therapeutic effectiveness of non-steroid anti-inflammatory drugs: comparative study. III]. Mariani L; Baratelli M Clin Ter; 1980 Feb; 92(4):331-58. PubMed ID: 7004749 [No Abstract] [Full Text] [Related]
6. [Adverse effects of antirheumatics in children and adolescents]. Hoza J; Rubín A; Fink Z; Havelka S Cesk Pediatr; 1984 Sep; 39(9):536-9. PubMed ID: 6334566 [No Abstract] [Full Text] [Related]
7. [Latest treatment methods in rheumatology]. Fellinger K Wien Med Wochenschr; 1973 Oct; 123(42):609-14. PubMed ID: 4583634 [No Abstract] [Full Text] [Related]
8. Adverse reactions to the principal drugs used in rheumatoid arthritis--a review. Franchimont P; Heynen G; Hauwaert CH J Rheumatol Suppl; 1978; 4():85-92. PubMed ID: 282449 [TBL] [Abstract][Full Text] [Related]
9. [Dosage and adverse effects of commonly used antirheumatic agents]. Mathies H Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):320-6. PubMed ID: 5317064 [No Abstract] [Full Text] [Related]
11. [Drug therapy of chronic juvenile arthritis]. Tulzer W Padiatr Padol; 1987; 22(2):199-210. PubMed ID: 3614954 [TBL] [Abstract][Full Text] [Related]
12. Disease-modifying agents and immunosuppressive drugs in the elderly. O'Callaghan JW; Brooks PM Clin Rheum Dis; 1986 Apr; 12(1):275-89. PubMed ID: 2872995 [TBL] [Abstract][Full Text] [Related]
13. [Rheumatoid arthritis in children. Bases for a rational treatment]. Saggese G; Biver P Minerva Pediatr; 1981 Aug; 33(16):781-804. PubMed ID: 6273706 [No Abstract] [Full Text] [Related]
14. The mechanism of action of antirheumatic agents. Mathies H Triangle; 1979; 18(2-3):63-73. PubMed ID: 44578 [No Abstract] [Full Text] [Related]
15. Office management of rheumatic disease. Pharmacology and laboratory evaluation. McWhorter JE Orthop Clin North Am; 1988 Oct; 19(4):867-75. PubMed ID: 3262853 [TBL] [Abstract][Full Text] [Related]
16. [Long term treatment of rheumatoid arthritis. Experiences with D-penicillamine in comparison with gold and immunosuppressive drugs (author's transl)]. Warnatz H; Scheiffarth F; Gutmann W Med Klin; 1975 Sep; 70(38):1509-15. PubMed ID: 810648 [TBL] [Abstract][Full Text] [Related]